Clinical Trial Update: Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Using Salmeterol as Active Control [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing indacaterol to salmeterol in COPD patients reports efficacy and safety data. The study is completed and results were posted on …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Indacaterol (indacaterol)
• Salmeterol (salmeterol)

Snippet

Sponsor: Novartis | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | Status: COMPLETED | Results posted: 2011-08-18